Petri Salvén

6.3k citations
50 papers · 5.1k indexed · h-index 29
Topics
Angiogenesis and VEGF in Cancer (37 papers)Lymphatic System and Diseases (14 papers)Vascular Tumors and Angiosarcomas (11 papers)

In The Last Decade

Petri Salvén

49 papers receiving 5.0k citations

Peers

Petri Salvén
Comparison fields: 5 of 105
  • Molecular Biology 3.4k
  • Oncology 2.4k
  • Cancer Research 1.1k
  • Surgery 528
  • Genetics 507
Replace Vladimir Joukov with:
Vladimir Joukov Finland
Peter Oettgen United States
Arja Kaipainen United States
Marcin Wysoczynski United States
Dorit Shweiki Israel
Sandra Ryeom United States
Pamela F. Jones United Kingdom
Tetsuro Watabe Japan
David J. Shields United States
Terhi Kärpänen Finland
Petri Salvén relative to Vladimir Joukov Finland Vladimir Joukov's profile →
Citations per field
00.5×1.5×2.2×
Vladimir Joukov · 1×
Citations per year

Countries citing papers authored by Petri Salvén

Since Specialization
Citations

This map shows the geographic impact of Petri Salvén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Salvén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Salvén more than expected).

Fields of papers citing papers by Petri Salvén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petri Salvén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Salvén. The network helps show where Petri Salvén may publish in the future.

Co-authorship network of co-authors of Petri Salvén

This figure shows the co-authorship network connecting the top 25 collaborators of Petri Salvén. A scholar is included among the top collaborators of Petri Salvén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petri Salvén. Petri Salvén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 24
2 6
3 122
4 29
5 51
6 28
7 294
8 25
9 9
10 16
11
Interferon alpha-2a therapy in 18 hemangioblastomas.
32
12 12
13 460
14 103
15 277
16
Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
2
17 232
18 121
19 231
20 43

About Petri Salvén

Petri Salvén is a scholar working on Oncology, Molecular Biology and Internal Medicine, having authored 50 papers that have together received 5.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (37 papers), Lymphatic System and Diseases (14 papers) and Vascular Tumors and Angiosarcomas (11 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.1k citations) and Molecular Biology (3.4k citations). Petri Salvén has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Heikki Joensuu, Kari Alitalo, Arto Orpana, Lasse Teerenhovi, Päivi Heikkilä, Iiro Rajantie, Shahin Rafii, Riitta Alitalo, Tarja Ruotsalainen and Shentong Fang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026